Thromboembolic events during the perioperative period in patients undergoing permanent pacemaker implantation

Clinical Cardiology

Volumn 35, Issue 2, 2012, Pages 83-87

  Chen, Songwen ^a   Liu, Jing ^b   Pan, Wenzhi ^b   Liu, Shaowen ^a   Su, Yangang ^b   Bai, Jin ^b   Wang, Wei ^b   Ge, Junbo ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THROMBOEMBOLISM;

EID: 84862796063     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21955     Document Type: Article

References (24)

1. Spittell PC, Hayes DL., Venous complications after insertion of a transvenous pacemaker. Mayo Clin Proc. 1992; 67: 258-265.
2. Pasquariello JL, Hariman RJ, Yudelman IM, et al. Recurrent pulmonary embolization following implantation of transvenous pacemaker. Pacing Clin Electrophysiol. 1984; 7: 790-793. (Pubitemid 14039288)
3. Sgarbossa EB, Pinski SL, Maloney JD, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: relevance of clinical characteristics and pacing modalities. Circulation. 1993; 88: 1045-1053. (Pubitemid 23264021)
4. Yoshitomi H, Tanabe K, Asanuma T, et al. Influence of cardiac pacing mode on left atrial appendage flow velocity: implication to systemic embolism during VVI pacing. Echocardiography. 1998; 15: 473-478. (Pubitemid 28328591)
5. Ertas F, Gulec S, Dincer I, et al. Left atrial appendage function in patients with different pacing modes. Int J Cardiol. 2000; 73: 135-141. (Pubitemid 30245999)
6. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997; 350: 1210-1216. (Pubitemid 127445094)
7. Toff WD, Camm AJ, Skehan JD., Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med. 2005; 353: 145-155. (Pubitemid 41058346)
8. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 2006; 113: 2391-2397. (Pubitemid 43948046)
9. Giudici MC, Paul DL, Bontu P, et al. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol. 2004; 27: 358-360. (Pubitemid 38352516)
10. Michaud GF, Pelosi F Jr, Noble MD, et al. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol. 2000; 35: 1915-1918. (Pubitemid 30342875)
11. Capucci A, Santini M, Padeletti L, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005; 46: 1913-1920. (Pubitemid 41579816)
12. Langenfeld H, Grimm W, Maisch B, et al. Atrial fibrillation and embolic complications in paced patients. Pacing Clin Electrophysiol. 1988; 11: 1667-1672. (Pubitemid 19010506)
13. Nielsen JC, Kristensen L, Andersen HR, et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol. 2003; 42: 614-623. (Pubitemid 37000174)
14. Albers GW., Atrial fibrillation and stroke: three new studies, three remaining questions. Arch Intern Med. 1994; 154: 1443-1448. (Pubitemid 24208569)
15. Petersen P, Godtfredsen J., Embolic complications in paroxysmal atrial fibrillation. Stroke. 1986; 17: 622-626.
16. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31: 2369-2429.
17. Hammerstingl C, Omran H., Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation-a study in 200 patients. Europace. 2011; 13: 1304-1310.
18. Jamula E, Douketis JD, Schulman S., Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost. 2008; 6: 1615-1621.
19. Hart RG, Pearce LA, Aguilar MI., Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007; 146: 857-867. (Pubitemid 351650486)
20. Connolly SJ, Pogue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009; 360: 2066-2078.
21. Altman R, Luciardi HL, Muntaner J, et al. The antithrombotic profile of aspirin: aspirin resistance, or simply failure? Thromb J. 2004; 2: 1.
22. Lau CP, Tse HF, Cheng G., Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients. Heart. 1997; 78: 358-363. (Pubitemid 27479637)
23. Fazio S, Cittadini A, Sabatini D, et al. Platelet aggregability in patients with a VVI pacemaker. Pacing Clin Electrophysiol. 1993; 16: 254-256. (Pubitemid 23095781)
24. Sohara H, Amitani S, Kurose M, et al. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1997; 29: 106-112. (Pubitemid 27028727)